EVO Evotec
- 5.250
- -0.240-4.37%
- 5.370
- +0.120+2.29%
Evotec News
Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024
HAMBURG, GERMANY / ACCESSWIRE / May 15, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first quarter of 2024
CENTOGENE and Evotec Unveil Potential Gaucher Disease Treatment
CENTOGENE And Evotec Announce Discovery Of New Molecule To Treat Gaucher Disease
CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies amend existing drug discovery partnership for Evotec to lead continued devel
Bayer and Evotec Collaborate to Advance Precision Cardiology
BAYER AND EVOTEC UPDATE FOCUS OF THEIR COLLABORATION TO CARDIOVASCULAR DISEASESSTRATEGIC ALLIANCE LEVERAGES HUMAN INDUCED PLURIPOTENT STEM CELL DISEASE MODELLING FOR IDENTIFICATION OF NOVEL TARGETSJOI
Evotec SE (ETR:EVT) Yearly Results: Here's What Analysts Are Forecasting For This Year
Evotec Is Maintained at Buy by HC Wainwright & Co.
Evotec Is Maintained at Buy by HC Wainwright & Co.
Evotec Price Target Cut to $11.00/Share From $14.00 by HC Wainwright & Co.
Evotec Price Target Cut to $11.00/Share From $14.00 by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Evotec, Lowers Price Target to $11
HC Wainwright & Co. analyst Douglas Tsao maintains Evotec with a Buy and lowers the price target from $14 to $11.
Evotec Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/25/2024 114.84% HC Wainwright & Co. $14 → $11 Maintains Buy 08/31/2023 173.44% HC Wainwright & Co. $12
Evotec Full Year 2023 Earnings: EPS Misses Expectations
Earnings Call Summary | Evotec(EVO.US) Q4 2023 Earnings Conference
The following is a summary of the Evotec SE (EVO) Q4 2023 Earnings Call Transcript:Financial Performance:Evotec reported a 4% increase with group revenues of €781.4 million for the year despite a cybe
Evotec EVO Earnings; Avenue ATXI Reverse Stock Split
Evotec Down Over 31%, On Track for Largest Percent Decrease Since October 2008 -- Data Talk
Evotec SE Sponsored ADR (EVO) is currently at $5.26, down $2.39 or 31.24% --Would be lowest close since April 5, 2017, when it closed at $5.25 --On pace for largest percent decrease since Oct. 10, 2
Crude Oil Moves Lower; B. Riley Financial Shares Jump
U.S. stocks traded slightly lower toward the end of trading, with the S&P 500 edging lower on Wednesday.The Dow traded down 0.18% to 38,434.99 while the NASDAQ fell 0.09% to 15,682.38. The S&P 500 als
Top Midday Decliners
Evotec (EVO) shares tumbled 33% after the company unveiled a "priority reset" of its business following the appointment of a new chief executive officer. Intraday volume topped 1.33 million shares ver
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Teledyne Technologies Incorporated (NYSE:TDY) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS
CSSE, RVYL and RCAT Among Mid-day Movers
Life Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast
Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Dow Jones falling over 100 points on Wednesday.
Nasdaq Rises 0.5%; Tesla Shares Jump After Q1 Results
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 0.5% on Wednesday.Following the market opening Wednesday, the Dow traded down 0.10% to 38,465.33 while the NASDAQ rose 0
Analysis
Price Target
No Data
